The latest highlights from DSM

On 1 August DSM reported a good H1 2019 and maintained the full year outlook previously raised from initial targets as detailed in the announcement of its Q1 Results on 7 May 2019.

The I AM Tomorrow Challenge is an acceleration program for startups and scaleups focused on data analytics, AI and other software solutions for large-scale 3D printing.

In the next step towards commercial availability, DSM has filed for EU authorization of a new feed additive for dairy cows that will reduce their methane emissions by around 30%.

The Evonik/DSM joint venture Veramaris has begun commercial scale production of omega-3 fatty acids rich in EPA and DHA from natural marine algae to feed salmon sustainably.

DSM partners with Avril to produce a unique protein based on non-genetically modified canola, enabling our customers to meet the growing consumer demand for plant-based proteins.

Silky UV is the latest addition to our family of 'haptic' resins giving brands the extra edge; packaging that doesn't just look good, it feels good too.

DSM & TFL, a leading manufacturer of specialty chemicals for the leather industry, collaborate on next-generation waterborne polyurethane dispersions based on renewable raw materials.

Amid dramatic demographic shifts in the region, a recent DSM Health Concerns survey showed that brain health and cognition are amongst the main concerns of consumers in Asia Pacific.

DSM broadens portfolio of yeast and enzymes for starch, fiber and biomass conversion products, bringing higher performance, better efficiency and more reliability to the biofuels industry.

Arnitel® increasingly being used as a lighter, smarter, greener alternative to conventional rubbers - reducing environmental impact and system costs.

DSM and the Chenyang Group, a world-leading manufacturer of environmentally friendly paints and coatings, are to collaborate more extensively to drive sustainable coating solutions in China.

Follow DSM's innovation partners Team Sunweb as we highlight the nutrition solutions and advanced technologies we are co-developing to protect the riders and aid their post-race recovery.

DSM is developing the world’s first durable and cost-effective transcatheter replacement heart valves to help tackle RHD, a major preventable cause of cardiovascular death and disability.

Building on an established presence of more than 30 years, the new Bangkok office serves as catalyst for growth and signals DSM’s intent to further develop its’ operations in Thailand.
 

DSM announces it is to acquire the engineering plastics business of SRF Ltd, a leader in developing and producing specialty materials for the automotive and electrical & electronics industries in India.

On 8 May 2019 DSM's proposal to declare a dividend for the financial year 2018 of €2.30 per ordinary share was adopted at the AGM. This represents an increase of €0.45, about 25%, on the €1.85 paid for 2017.

Feike Sijbesma, CEO/Chairman DSM Managing Board, commented: “I am pleased to report a good start to the year, with continued positive momentum, led by our Nutrition business, while Materials continues to demonstrate its resilience."

Feike Sijbesma, CEO/Chairman DSM Managing Board, commented: “I am pleased to report a good start to the year, with continued positive momentum, led by our Nutrition business, while Materials continues to demonstrate its resilience."